Nagayama Daiji, Shirai Kohji
Center of Diabetes, Endocrine and Metabolism, Toho University Sakura Medical Center.
Nihon Rinsho. 2009 Feb;67(2):385-91.
Principle of the treatment of obesity is diet and exercise therapy. However, it is extremely difficult to maintain the effect in the long term. In recent years, mechanism of appetite center and adaptive thermogenesis is gradually clarified. As a tool of new treatment of obesity, anti-obesity drugs come to attract attention in this way. However, anti-obesity drug is not the all-around procedure that has got thinner easily if we use it. Anti-obesity drug should be used carefully to show the availability after having understood each action mechanism. Other than mazindol approved alone in Japan, we explain it in this chapter about sibutramine and rimonabant those are on the clinical trial now. We will mention an adaptation of a certain anti-obesity drug in the middle of an argument.
肥胖症的治疗原则是饮食和运动疗法。然而,长期维持疗效极其困难。近年来,食欲中枢和适应性产热的机制逐渐得以阐明。作为肥胖症新的治疗手段,减肥药因此开始受到关注。然而,减肥药并非那种使用后就能轻松瘦身的万全之策。在了解每种作用机制后,应谨慎使用减肥药以发挥其效用。除了在日本单独获批的马吲哚外,本章将对目前正处于临床试验阶段的西布曲明和利莫那班进行阐释。我们将在论述过程中提及某种减肥药的适用情况。